Contrast Nephropathy and Nitrates (CoNaN)
Sponsor: Florida Heart Research Institute
Listed as NCT01999517, this PHASE4 trial focuses on Contrast Induced Nephropathy and remains completed. Sponsored by Florida Heart Research Institute, it has been updated 10 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2018 — Nov 2019 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Florida Heart Research Institute
- Mt. Sinai Medical Center, Miami
For direct contact, visit the study record on ClinicalTrials.gov .